- Home
- ABOS vs ALAR Comparison
ABOS vs ALAR Comparison
Compare ABOS & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- ALAR
- Stock Information
- Founded
- ABOS 1996
- ALAR 2013
- Country
- ABOS United States
- ALAR Israel
- Employees
- ABOS N/A
- ALAR N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- ALAR Computer Software: Prepackaged Software
- Sector
- ABOS Health Care
- ALAR Technology
- Exchange
- ABOS Nasdaq
- ALAR Nasdaq
- Market Cap
- ABOS 103.6M
- ALAR 105.3M
- IPO Year
- ABOS 2021
- ALAR 2018
- Fundamental
- Price
- ABOS $1.88
- ALAR $15.01
- Analyst Decision
- ABOS Strong Buy
- ALAR Strong Buy
- Analyst Count
- ABOS 3
- ALAR 1
- Target Price
- ABOS $8.00
- ALAR $27.00
- AVG Volume (30 Days)
- ABOS 410.3K
- ALAR 65.6K
- Earning Date
- ABOS 11-11-2025
- ALAR 11-24-2025
- Dividend Yield
- ABOS N/A
- ALAR N/A
- EPS Growth
- ABOS N/A
- ALAR N/A
- EPS
- ABOS N/A
- ALAR 0.07
- Revenue
- ABOS N/A
- ALAR $30,488,000.00
- Revenue This Year
- ABOS N/A
- ALAR $28.77
- Revenue Next Year
- ABOS N/A
- ALAR $31.83
- P/E Ratio
- ABOS N/A
- ALAR $19.30
- Revenue Growth
- ABOS N/A
- ALAR N/A
- 52 Week Low
- ABOS $0.86
- ALAR $5.45
- 52 Week High
- ABOS $3.36
- ALAR $21.50
- Technical
- Relative Strength Index (RSI)
- ABOS 67.95
- ALAR 47.58
- Support Level
- ABOS $1.67
- ALAR $14.51
- Resistance Level
- ABOS $1.86
- ALAR $15.74
- Average True Range (ATR)
- ABOS 0.16
- ALAR 0.68
- MACD
- ABOS 0.06
- ALAR -0.10
- Stochastic Oscillator
- ABOS 73.86
- ALAR 26.56
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.